Search For "glp 1"
CDSCO issues advisory to curb misleading promotion of prescription medicat
Updated : 2 months, 1 week ago IST
The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 in the promotion and marketin
Read More
Generic Semaglutide patent expiry opens over Rs 50,000 Crore opportunity f
Updated : 4 months, 2 weeks ago IST
In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth by 0.5-1%. Prices are anticipated to be 30-50% lower than current levels initially, with the potential for deeper cuts of up to 70-75% o
Read More
India and Obesity: SMSRC Insights Report reveals the weight of opportunity
Updated : 5 months, 2 weeks ago IST
New Delhi [India], December 3: India stands at an inflexion point in its battle with obesity. For many years, obesity remained peripheral to mainstream clinical focus, overshadowed by diabetes, cardiovascular disease and chronic respiratory illness. New real-world evidence from the latest "S
Read More
WHO issues a global guideline on the use of GLP-1 medicines in treating ob
Updated : 5 months, 3 weeks ago IST
Obesity affects people in every country and was associated with 3.7 million deaths worldwide in 2024. Without decisive action, the number of people with obesity is projected to double by 2030.
Read More
MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub to Improve Acces
Updated : 6 months, 3 weeks ago IST
Bengaluru (Karnataka) [India], October 28: MrMed, India's largest online super-specialty pharmacy, has opened a state-of-the-art cold-chain distribution hub in Bengaluru. The new facility strengthens the company's ability to deliver temperature-sensitive medicines especially GLP-1 therapies
Read More
NoGuilt Fitness Launches Fitty GLP-1 Daily: a Clinical Solution for Health
Updated : 7 months ago IST
Chandigarh [India], October 24: NoGuilt Fitness, a homegrown health and wellness company focused on sustainable transformation, has launched Fitty GLP-1 Daily, a science-backed supplement aimed at supporting healthy weight loss, healthy metabolism, and balanced blood sugar levels. The produc
Read More
CDSCO approves Danish drugmaker Novo Nordisk's injection for Type 2 diabet
Updated : 7 months, 3 weeks ago IST
In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals with Type 2 diabetes and will be available only upon a doctor's prescription.
Read More
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3
Updated : 1 year, 1 month ago IST
According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial."
Read More
This protein likely to help retain muscle mass without fat loss: Study
Updated : 7 months, 3 weeks ago IST
The recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, has resulted in renewed scientific interest in understanding how our bodies regulate muscle growth. In a recent study, scientists have linked the protein BCL6 to the maintenance of muscle mass and fur
Read More
Semaglutide ingredient can help protect kidney function in people with obe
Updated : 1 year, 12 months ago IST
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes
Read More
Higher oral semaglutide dosage helps in weight loss, blood sugar regulatio
Updated : 2 years, 10 months ago IST
Diabetes is a chronic disease that makes controlling blood sugar levels challenging. For many individuals, the problem gets worse with time, making blood sugar management more challenging. Semaglutide is one example of GLP-1 receptor agonist that has provided patients with better control ove
Read More
Study discovers how higher doses of oral semaglutide improve blood sugar c
Updated : 2 years, 7 months ago IST
Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the condition worsens with time, making it harder to control blood sugar levels. Semaglutide is one example of a GLP-1 receptor agonist that has given patients more control over blood sug
Read More